Nasdaq:US$16.39 (+0.41) | HKEX:HK$25.40 (-0.34) | AIM:£2.44 (+0.07)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Careers
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Careers
Shareholder Information
Hutchmed
| Shareholder Information
SHARE PRICE CHART
Nasdaq:HCM
US$16.39
+0.41 | 9 Oct 2025 | 16:10EDT
Market cap (M): US$2,858.78
HKEX:13
HK$25.40
-0.34 | 9 Oct 2025 | 16:08HKT
Market cap (M): HK$22,152.58
London AIM:HCM
£2.44
+0 | 9 Oct 2025 | 10:01BST
Market cap (M): £2,128.04
CORPORATE PRESENTATION
31 Aug 2025
Corporate Presentation for Investors
Read more
See all
Announcements
Latest announcements
Financial Reports
Annual Reports (with 20-F) and Interim Reports
EVENTS, PRESENTATIONS & CIRCULARS
HUTCHMED R&D Updates
2025-10-31
Corporate Presentation for Investors
2025-08-31
2025 Half-Year Financial Results
2025-08-07 - 2025-08-08
2025 ASCO Update Investor Call
2025-06-03
MAJOR SHAREHOLDERS
Directors and Significant Shareholders
Information for Shareholders
Share-related address & contact information
Listing FAQs for Shareholders
Frequently asked questions about HUTCHMED's HKEX, Nasdaq and AIM share listings
SEC Filings
AIM RULE 26 DISCLOSURES
Disclosure reference pursuant to Rule 26 'Company Information' of the AIM Rules of Companies
Warning to Shareholders
Avoiding share fraud
ANALYST COVERAGE
